Cargando…

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Induced Severe Atypical Rash in a Patient of Non-Hodgkin's Lymphoma

Granulocyte-macrophage colony-stimulating factor (GM-CSF) infusion has been reported with the development of transient maculopapular rash with spontaneous resolution. A 54-year-old Indian female developed intense erythematous generalised rash involving the face, trunk, extremities, palms and soles f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Gautam Kumar, Bhatnagar, Anuj, Mitra, Debdeep, Sharma, Pooja, Singh, Abhay, Mitra, Barnali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455089/ https://www.ncbi.nlm.nih.gov/pubmed/36092242 http://dx.doi.org/10.4103/ijd.ijd_66_21

Ejemplares similares

Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
por: Bo, Lulong, et al.
Publicado: (2011)

Hypertrophied Nodules over a Red Birth Mark
por: Mitra, Debdeep, et al.
Publicado: (2022)

Use of 27-gauge Tuberculin Syringe for Trichloroacetic Acid Chemical Reconstruction of Skin Scars (TCA-CROSS)
por: Mitra, Debdeep, et al.
Publicado: (2021)

A case of paracoccidioidomycosis in a HIV-positive patient
por: Mitra, Debdeep, et al.
Publicado: (2021)

Unusual Spurts of Rosacea Like Dermatoses, Posing a Diagnostic Dilemma During Covid-19 Pandemic: A Cross-Sectional, Observational Study From a Tertiary Care Centre
por: Singh, Gautam Kumar, et al.
Publicado: (2021)

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease
por: Cook, Andrew D, et al.
Publicado: (2001)

Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
por: Mitra, Debdeep, et al.
Publicado: (2022)

Psoriasiform eruption triggered by recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and exacerbated by granulocyte colony stimulating factor (rG-CSF) in a patient with breast cancer.
por: Cho, S. G., et al.
Publicado: (1998)

Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances cumulus cell expansion in bovine oocytes
por: Peralta, Oscar A, et al.
Publicado: (2013)

The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease
por: Jones, Thomas C.
Publicado: (1996)

A case of primary and secondary syphilis presenting together as immune reconstitution inflammatory syndrome
por: Mitra, Debdeep, et al.
Publicado: (2021)

Granulocyte-macrophage colony-stimulating factor (GM-CSF) in subjects with different stages of periodontitis according to the new classification
por: Dikilitas, Ahu, et al.
Publicado: (2022)

Recombinant human macrophage colony-stimulating factor (M-CSF) requires subliminal concentrations of granulocyte/macrophage (GM)-CSF for optimal stimulation of human macrophage colony formation in vitro
Publicado: (1987)

Up-Regulation of Cluster of Differentiation (CD) 11b Expression on the Surface of Canine Granulocytes with Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
por: NAKAGAKI, Kazuhide, et al.
Publicado: (2014)

Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.
por: Steward, W. P., et al.
Publicado: (1990)

Detection and assessment of human tumours producing granulocyte-macrophage colony-stimulating factor (GM-CSF) by heterotransplantation into nude mice.
por: Asano, S., et al.
Publicado: (1980)

Chimeric HIV-1 Envelope Glycoproteins with Potent Intrinsic Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Activity*
por: Isik, Gözde, et al.
Publicado: (2013)

Effects of Granulocyte-Macrophage Colony-Stimulating (GM-CSF) Factor on Corneal Epithelial Cells in Corneal Wound Healing Model
por: Rho, Chang Rae, et al.
Publicado: (2015)

A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients
por: Guan, Jin-Tao, et al.
Publicado: (2021)

Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases
por: Chen, Tempe K, et al.
Publicado: (2022)

Involvement of a phospholipase D in the mechanism of action of granulocyte-macrophage colony-stimulating factor (GM-CSF): priming of human neutrophils in vitro with GM-CSF is associated with accumulation of phosphatidic acid and diradylglycerol
Publicado: (1990)

Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody
por: Papp, K.A., et al.
Publicado: (2018)

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Augments Acute Lung Injury via Its Neutrophil Priming Effects
por: Choi, Jae Chol, et al.
Publicado: (2008)

Granulocyte-macrophage colony stimulating factor (GM-CSF) is fully expressed in the genital tract, seminal plasma and spermatozoa of male pigs
por: Padilla, Lorena, et al.
Publicado: (2020)

Correspondence to: “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.”
por: Bansal, Pankaj, et al.
Publicado: (2021)

Granulocyte-macrophage colony-stimulating factor (GM-CSF) shows therapeutic effect on dimethylnitrosamine (DMN)-induced liver fibrosis in rats
por: Karmacharya, Mrigendra Bir, et al.
Publicado: (2022)

Efficacy and safety of granulocyte–macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis
por: Xi, An-ran, et al.
Publicado: (2022)

Pruritic Rash in a Patient with Hodgkin's Lymphoma
por: Le, Audrey, et al.
Publicado: (2018)

812. Case–Control Trial to Evaluate the Cytokine Response to the Use of Capsule Thalidomide in Erythema Nodosum Leprosum in Leprosy Patients
por: Chopra, Ajay, et al.
Publicado: (2018)

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Downregulates the Expression of Protumor Factors Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in a GM-CSF Receptor-Independent Manner in Cervical Cancer Cells
por: Jiang, Nanyan, et al.
Publicado: (2015)

Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.
por: Yokose, N., et al.
Publicado: (1998)

The hematopoietic factor GM-CSF (Granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro
por: Krüger, Carola, et al.
Publicado: (2007)

RETRACTION NOTICE: A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients
Publicado: (2021)

Nebulised granulocyte–macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis
por: Munsif, Maitri, et al.
Publicado: (2023)

Distinct macrophage phenotypes skewed by local granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis
por: Jiemy, William F, et al.
Publicado: (2020)

Acrodermatitis Continua of Hallopeau: A Diagnostic Challenge
por: Mitra, Debdeep, et al.
Publicado: (2022)

Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells
por: Klimp, A H, et al.
Publicado: (1999)

cAMP analogues downregulate the expression of granulocyte macrophage colony-stimulating factor (GM-CSF) in human bone marrow stromal cells in vitro.
por: Bug, G, et al.
Publicado: (1998)

The addition of granulocyte macrophage colony stimulating factor (GM-CSF) to juvenile systemic lupus erythematosus serum can reduce abnormal neutrophil apoptosis
por: Midgley, AJ, et al.
Publicado: (2008)

Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’
por: Guan, Jin-Tao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gnmgcfdbsod8boq8tne9cqha1i